These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8504408)
1. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Lu C; Rak JW; Kobayashi H; Kerbel RS Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408 [TBL] [Abstract][Full Text] [Related]
2. Oncostatin M is a differentiation factor for myeloid leukemia cells. Bruce AG; Hoggatt IH; Rose TM J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037 [TBL] [Abstract][Full Text] [Related]
3. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065 [TBL] [Abstract][Full Text] [Related]
4. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression. Rak JW; Hegmann EJ; Lu C; Kerbel RS J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678 [TBL] [Abstract][Full Text] [Related]
6. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575 [TBL] [Abstract][Full Text] [Related]
7. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells. Lu C; Sheehan C; Rak JW; Chambers CA; Hozumi N; Kerbel RS Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M. Silvani A; Ferrari G; Paonessa G; Toniatti C; Parmiani G; Colombo MP Cancer Res; 1995 May; 55(10):2200-5. PubMed ID: 7743524 [TBL] [Abstract][Full Text] [Related]
9. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682 [TBL] [Abstract][Full Text] [Related]
11. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production. Terada S; Suzuki E; Ueda H; Makishima F Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746 [TBL] [Abstract][Full Text] [Related]
12. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6). McDonald VL; Dick KO; Malik N; Shoyab M Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294 [TBL] [Abstract][Full Text] [Related]
13. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000 [TBL] [Abstract][Full Text] [Related]
14. Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form. Heymann D; Godard A; Raher S; Ringeard S; Lassort D; Blanchard F; Harb J Cytokine; 1995 Feb; 7(2):111-7. PubMed ID: 7780030 [TBL] [Abstract][Full Text] [Related]
15. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. MacDougall JR; Bani MR; Lin Y; Rak J; Kerbel RS Cancer Res; 1995 Sep; 55(18):4174-81. PubMed ID: 7664294 [TBL] [Abstract][Full Text] [Related]
16. Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes. Lacreusette A; Lartigue A; Nguyen JM; Barbieux I; Pandolfino MC; Paris F; Khammari A; Dréno B; Jacques Y; Blanchard F; Godard A J Pathol; 2008 Dec; 216(4):451-9. PubMed ID: 18798220 [TBL] [Abstract][Full Text] [Related]
17. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression. Westendorf JJ; Jelinek DF J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418 [TBL] [Abstract][Full Text] [Related]
18. Upmodulation of alpha v beta 1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M: correlation with increased cell adhesion on fibronectin. Heymann D; Harb J; Ringeard S; Blanchard F; Lassort D; Raher S; Godard A J Cell Biochem; 1995 Jul; 58(3):305-14. PubMed ID: 7593253 [TBL] [Abstract][Full Text] [Related]
19. Establishment of SSEA-1- and Oct-4-expressing rat embryonic stem-like cell lines and effects of cytokines of the IL-6 family on clonal growth. Vassilieva S; Guan K; Pich U; Wobus AM Exp Cell Res; 2000 Aug; 258(2):361-73. PubMed ID: 10896787 [TBL] [Abstract][Full Text] [Related]
20. Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells. Lacreusette A; Barbieux I; Nguyen JM; Pandolfino MC; Dréno B; Jacques Y; Godard A; Blanchard F J Pathol; 2009 Apr; 217(5):665-76. PubMed ID: 19097071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]